Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2022-07-18 00:00:00 ET · period of report 2022-07-18 · accession 0001450324-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-18 | 2022-07-18 | AIM | Equels Thomas K | CEO, Pres, Dir | A - Grant | $0.76 | +32.9K | 382.7K | +9% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-18 | A | A | 32,895 | $0.76 | 382,704 | D | — | — |